BNP PARIBAS FINANCIAL MARKETS - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 134 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2019. The put-call ratio across all filers is 3.35 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$423,808
+111.9%
77,763
+160.9%
0.00%
Q2 2023$200,005
-65.4%
29,807
-54.5%
0.00%
-100.0%
Q1 2023$578,383
+91.4%
65,502
+65.6%
0.00%
Q4 2022$302,154
-99.9%
39,549
-53.0%
0.00%
-100.0%
Q3 2022$598,529,000
+94.9%
84,063
+121.4%
0.00%
Q2 2022$307,161,000
+160.8%
37,968
+347.5%
0.00%
Q1 2022$117,772,000
+34.3%
8,485
+171.4%
0.00%
Q4 2021$87,716,000
-17.4%
3,126
+0.1%
0.00%
Q3 2021$106,151,000
+55.0%
3,123
+86.3%
0.00%
Q2 2021$68,481,000
-48.9%
1,676
-49.7%
0.00%
Q1 2021$134,106,000
-17.1%
3,331
+21.7%
0.00%
Q4 2020$161,839,000
+182.0%
2,737
+131.9%
0.00%
Q3 2020$57,383,000
-59.8%
1,180
-60.1%
0.00%
Q2 2020$142,915,000
+218.7%
2,954
+83.0%
0.00%
Q1 2020$44,837,000
+89.9%
1,614
+104.6%
0.00%
Q4 2019$23,607,000
+14.0%
789
+17.8%
0.00%
Q3 2019$20,703,0006700.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2019
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders